Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer

Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer

Breast Cancer (BC) is the second most common type of cancer worldwide and displays the highest cancer-related mortality among women worldwide. Targeted therapies have revolutionized the way BC has been treated in recent decades, improving the life expectancies of millions of women. Among the differe...

Full description

Bibliographic Details
Main Authors: Navid Sobhani, Alberto D’Angelo, Matteo Pittacolo, Giandomenico Roviello, Anna Miccoli, Silvia Paola Corona, Ottavia Bernocchi, Daniele Generali, Tobias Otto
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Cells
Subjects:
cyclin-dependent kinases
cyclin-dependent kinase 4 and 6 inhibitors
targeted therapies
breast cancer
Online Access:https://www.mdpi.com/2073-4409/8/4/321

Internet

https://www.mdpi.com/2073-4409/8/4/321

Similar Items